Abiopharma

🔍 WELLS FARGO & COMPANY/MN (Executive)

Company: NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND (NXJ)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Sold 2,329 shares of Variable Rate Demand Preferred Shares (Direct)
  Date: 2026-04-27 | Code: J | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2

Footnotes:

• F1: In connection with the reorganization of the Issuer into NUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUND ("NMZ"), 2,329 variable rate demand preferred shares (the "VRDP Shares") of the Issuer beneficially owned by Wells Fargo Municipal Capital Strategies, LLC ("Capital Strategies") were exchanged for an equal number of VRDP Shares of NMZ in a cashless transaction. The 2,329 shares reported as disposed of in Table I represent shares that were beneficially owned by Capital Strategies. Capital Strategies is a wholly owned subsidiary of Wells Fargo & Company ("Wells Fargo").
• F2: This statement is jointly filed by Wells Fargo and Capital Strategies. Wells Fargo holds an indirect interest in the securities listed in Table I by virtue of its indirect ownership of its subsidiary Capital Strategies.
• F3: Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
• REMARKS: Exhibits Index Exhibit 99.1 - Joint Filing Agreement Exhibit 99.2 - Joint Filer Information